Pearce Samantha 4
4 · Jazz Pharmaceuticals plc · Filed Mar 7, 2025
Insider Transaction Report
Form 4
Pearce Samantha
EVP, Chief Commercial Officer
Transactions
- Disposition to Issuer
Ordinary Shares
2025-03-05$138.95/sh−1,905$264,700→ 41,226 total
Footnotes (1)
- [F1]Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.